EP4538227A3 — Sodium thiosulfate-containing pharmaceutical compositions
Assigned to Hope Medical Enterprises Inc · Expires 2025-06-25 · 1y expired
What this patent protects
Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the admi…
USPTO Abstract
Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
Drugs covered by this patent
- Sodium Nitrite (SODIUM NITRITE) · Hope Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.